Healthcare provider profile · identity verified

Ellen Cecchetti, CRNP

Nurse Practitioner · KANE, PA · NPI 1467498592

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	317	88
Lisinopril	Lisinopril	287	79
Omeprazole	Omeprazole	252	54
Gabapentin	Gabapentin	208	42
Hydrochlorothiazide	Hydrochlorothiazide	203	51
Metoprolol Succinate	Metoprolol Succinate	203	43
Amlodipine Besylate	Amlodipine Besylate	198	54
Losartan Potassium	Losartan Potassium	189	51
Pantoprazole Sodium	Pantoprazole Sodium	188	40
Simvastatin	Simvastatin	184	46
Levothyroxine Sodium	Levothyroxine Sodium	143	32
Lorazepam	Lorazepam	127	28
Jardiance	Empagliflozin	119	22
Metformin Hcl	Metformin Hcl	118	30
Famotidine	Famotidine	106	23
Fluticasone Propionate	Fluticasone Propionate	102	34
Metoprolol Tartrate	Metoprolol Tartrate	100	30
Alprazolam	Alprazolam	98	16
Sertraline Hcl	Sertraline Hcl	95	24
Eliquis	Apixaban	93	14
Duloxetine Hcl	Duloxetine Hcl	92	18
Carvedilol	Carvedilol	89	21
Atenolol	Atenolol	88	22
Montelukast Sodium	Montelukast Sodium	86	17
Potassium Chloride	Potassium Chloride	82	18
Allopurinol	Allopurinol	81	22
Rosuvastatin Calcium	Rosuvastatin Calcium	79	23
Furosemide	Furosemide	73	20
Clopidogrel	Clopidogrel Bisulfate	71	14
Hydralazine Hcl	Hydralazine Hcl	71	14
Albuterol Sulfate Hfa	Albuterol Sulfate	67	20
Metformin Hcl Er	Metformin Hcl	63	19
Alendronate Sodium	Alendronate Sodium	56	11
Tramadol Hcl	Tramadol Hcl	53	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	50	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	13
Synthroid	Levothyroxine Sodium	46	suppressed
Methylprednisolone	Methylprednisolone	45	38
Trazodone Hcl	Trazodone Hcl	45	suppressed
Meloxicam	Meloxicam	44	suppressed
Trulicity	Dulaglutide	43	suppressed
Glipizide Er	Glipizide	41	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Pravastatin Sodium	Pravastatin Sodium	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Fentanyl	Fentanyl	34	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	34	suppressed
Valsartan	Valsartan	34	suppressed
Baclofen	Baclofen	33	suppressed
Meclizine Hcl	Meclizine Hcl	33	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	30
Celecoxib	Celecoxib	32	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Pregabalin	Pregabalin	28	suppressed
Azithromycin	Azithromycin	27	24
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Topiramate	Topiramate	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	23	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Bumetanide	Bumetanide	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	20	15
Digoxin	Digoxin	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Bydureon Bcise	Exenatide Microspheres	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Glipizide	Glipizide	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Cephalexin	Cephalexin	14	12
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Clonazepam	Clonazepam	13	suppressed
Diazepam	Diazepam	13	suppressed
Humalog Kwikpen U-200	Insulin Lispro	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Enalapril Maleate	Enalapril Maleate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Insulin Glargine Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	12	suppressed
Ozempic	Semaglutide	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Risperidone	Risperidone	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error